Germany
# |
Name |
Goodwill |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 49.15 M
|
Dec. 31, 2023 | USD 55.66 | 3.14% |
|
Germany |
|
2 |
USD 6.65 M
|
Nov. 30, 2023 | USD 2.56 | 1.91% |
|
Germany |
|
3 |
USD 6.62 M
|
Dec. 31, 2023 | USD 42.86 | 0.25% |
|
Germany |
|
4 |
USD 0.00
|
Dec. 31, 2023 | USD 5.47 | 1.30% |
|
Germany |
|
5 |
USD 0.00
|
Dec. 31, 2023 | USD 1.55 | -3.12% |
|
Germany |
|
6 |
USD 0.00
|
Dec. 31, 2023 | USD 7.30 | 4.29% |
|
Germany |
|
7 |
USD 0.00
|
Dec. 31, 2023 | USD 2.41 | 1.69% |
|
Germany |
|
8 |
USD 0.00
|
Dec. 31, 2023 | USD 2.04 | 1.81% |
|
Germany |
The Clinical Trials company in Germany with the highest Goodwill is Formycon AG (XETRA: FYB.DE) at USD 49.15 M.
The Clinical Trials company in Germany with the lowest Goodwill is Vivoryon Therapeutics N.V. (Amsterdam Stock Exchange: VVY.AS) at USD 0.00.
The top 10 Clinical Trials companies in Germany by Goodwill are Formycon AG, Heidelberg Pharma AG, Biotest AG, Immatics N.V., Atai Life Sciences N.V., Mainz Biomed B.V., InflaRx N.V. and Vivoryon Therapeutics N.V..
The bottom 10 Clinical Trials companies in Germany by Goodwill are Vivoryon Therapeutics N.V., InflaRx N.V., Mainz Biomed B.V., Atai Life Sciences N.V., Immatics N.V., Biotest AG, Heidelberg Pharma AG and Formycon AG.